Ethical issues in intervention studies on the management of treatment of diabetes and hypertension in sub-Saharan Africa.

Shayo, E, Van Hout, MC, Birungi, J, Garrib, A, Kivuyo, S, Mfinanga, S, Nyirenda, M, Namakoola, I, Okebe, J, Ramiya, K, Bachmann, M, Cullen, W, Lazarus, J, Gill, G, Shiri, T, Bukenya, D, Snell, H, Nanfuka, M, Cuevas, L, Shimwela, M et al (2020) Ethical issues in intervention studies on the management of treatment of diabetes and hypertension in sub-Saharan Africa. BMJ Global Health, 5 (7). ISSN 2059-7908

[thumbnail of e002193.full.pdf]
Preview
Text
e002193.full.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (344kB) | Preview

Abstract

The incidence of diabetes and hypertension has risen sharply in sub-Saharan Africa alongside a continuing high burden of HIV-infection. In many settings, the prevalence figures among adults are 4-5% for diabetes, above 25% for hypertension and 5-20% for HIVinfection. All these conditions require life-long treatment and they have increased substantially the demand for chronic care services in Africa, where health systems have, until recently, focussed on tackling acute infectious diseases.

Item Type: Article
Subjects: R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Divisions: Public and Allied Health
Publisher: BMJ Publishing Group
Date of acceptance: 5 June 2020
Date of first compliant Open Access: 12 January 2022
Date Deposited: 04 Jun 2020 11:45
Last Modified: 12 Jan 2022 15:30
URI: https://researchonline.ljmu.ac.uk/id/eprint/13046
View Item View Item